Cardiovascular Health

Pharmacist education also helps prevent adverse reactions, maximizes outcomes for the symptomless disease.

Excess drinking is a major atrial fibrillation risk factor in young people.

Modification is based on phase 3 FIGARO-DKD clinical trial investigating CV and kidney outcomes in more than 13,000 patients with CKD associated with type 2 diabetes.

Analysis presented at an American Heart Association meeting suggests that following DASH is most effective to reduce the risk of heart attacks and strokes.

The findings also indicate that that treatment may have protective CV and limb benefits for those with kidney failure and concomitant peripheral artery disease.

Patients should discuss efficacy and potential drug interactions with clinicians before use, study authors indicate.

Researchers suggest that dentists who do not administer antibiotics to high-risk patients for infective endocarditis could be risking the patient’s life.

A new statement from the American Heart Association stresses withdrawal medications and special care teams to prevent endocarditis in these individuals.

The benefits of taking a daily statin may improve as a patient grows older.

Some function is partially restored once smokers kick the habit, results presented at the European Society of Cardiology Congress 2022 show.

New research suggests that icosapent ethyl can significantly decrease cardiovascular risk among former or current smokers with other cardiovascular risk factors.

In a recent survey, researchers identified rising costs, socioeconomic inequity, and drug trends as major concerns for large employers.

The phase 2 study will evaluate the efficacy and safety of 2 different doses of MK-2060 in patients with ESRD receiving hemodialysis via an arteriovenous graft.

Analysis includes nearly 43 million individuals aged 13 year and older who received at least 1 dose in England between December 1, 2020, and December 15, 2021.

The American Heart Association includes 6 conditions and indicates that men’s and women’s experiences may differ.

Investigators reported that people who frequently naps may have an increased risk of high blood pressure and ischemic stroke by 12% compared to people who do not nap.

Advise restriction of the nutrient, along with intensive BP control, regimens promoting adherence, use of chlorthalidone in CKD.

Patients with gout have a 4 times greater risk of a cardiovascular episode within the 60 days following their flare up.

New research links some beta-blockers and antiplatelet medications with a higher risk of experiencing a heart attack in hot weather.

A daily serving of meat can increase the risk of cardiovascular disease by 22% and our own gut microbes may contribute to this risk.

A new study predicts significant increases in cardiovascular issues in the United States, highlighting racial and ethnic inequality of future patients.

Cangrelor (Kengreal) is indicated as an adjunct to percutaneous coronary intervention for reducing the risk of periprocedural myocardial infarction, repeat coronary revascularization, and stent thrombosis.

Dalteparin sodium (Fragmin) is indicated for the extended treatment of symptomatic venous thromboembolism (VTE) to reduce VTE recurrence in adult patients with cancer, as well as several other indications.

While the vaccines continue to provide critical, evidence-based protection against the coronavirus, rare cases of myocarditis and pericarditis have been reported.

Pharmacist interventions can provide patient-specific guidance to identify and solve problems with medication regimens to ensure optimal outcomes.

Ezetimibe (Zetia) is an inhibitor of intestinal cholesterol and related phytosterol absorption indicated as an adjunct to diet to reduce elevated total cholesterol.

Pharmacists have a key role in monitoring patients on statin therapy and identifying statin intolerance.

It’s common practice to recommend heart failure patients follow low sodium diets, but research has shown this type of diet may worsen patient health for certain forms of the condition.

Study shows that adult survivors of cancer had a 42% greater risk of CVD than people who did not have the disease.

Fondaparinux sodium (Arixtra) is indicated for prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip fracture surgery (including extended prophylaxis), hip replacement surgery, knee replacement surgery, or abdominal surgery.